Author

Dorra Jedoui

Stanford Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Abhishek KoladiyaiD· 1 shared Ao WangiD· 1 shared Astraea Jager· 1 shared Charles Grenfell MullighaniD· 1 shared Felix J. HartmanniD· 1 shared Haowen JiangiD· 1 shared Jiangbin YeiD· 1 shared Jingjing Liu· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhishek KoladiyaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL

Yuxuan Liu, Haowen Jiang, Jingjing Liu, Lucille Stuani, Milton J. Merchant, Astraea Jager, Abhishek Koladiya, Ti‐Cheng Chang, Pablo Domizi, Jolanda Sarno, Timothy Keyes, Dorra Jedoui, Ao Wang, Jodie Meng, Felix J. Hartmann, , Kara Lynn Davis

This study identifies uridine metabolism as a therapeutic target for chemo-resistant B-ALL by linking active signaling to uridine dependency and demonstrating DHODH inhibition as a promising treatment.

bioRxiv · Jan 27, 2025 · PreprintCancer Biology